Literature DB >> 23949081

Extracorporeal Shock Wave Therapy reduces upper limb spasticity and improves motricity in patients with chronic hemiplegia: a case series.

Franco Troncati1, Matteo Paci, Tefta Myftari, Bruna Lombardi.   

Abstract

BACKGROUND: Extracorporeal Shock Wave Therapy (ESWT) has been proposed for treatment of abnormal muscle tone only in the last years. The effects on motor impairment are unknown.
OBJECTIVE: To assess the long-term effects of ESWT on muscle tone and motricity in upper limb in patients with chronic hemiplegia.
METHODS: Twelve patients were selected and treated with two sessions of ESWT. Participants were assessed at baseline, after the treatment, and at 3 and 6 months. Muscle tone of shoulder adductors, elbow, wrist and finger flexors was evaluated at all assessment points using the Modified Ashworth Scale (MAS), while motricity, passive range of motion (PROM) and pain sub-scores of upper extremity part of the Fugl-Meyer scale were used to assess motor recovery. The degree of perceived benefit from treatment was assessed on a visual analogue scale.
RESULTS: MAS showed a significant reduction of spasticity and Fugl-Meyer scores improved immediately after treatment. Persistent effects were observed at 3 and 6 months for MAS, and for motricity and PROM subscores of the Fugl-Meyer scale. Clinical improvement was not correlated to the patients' perceived benefit.
CONCLUSIONS: Two sessions of ESWT seem to have long-term effects in reducing muscle tone and enhancing motor impairment.

Entities:  

Keywords:  Extracorporeal shock wave therapy; muscle spasticity; paresis; rehabilitation; stroke

Mesh:

Year:  2013        PMID: 23949081     DOI: 10.3233/NRE-130970

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  7 in total

1.  A Prospective Case-Control Study of Radial Extracorporeal Shock Wave Therapy for Spastic Plantar Flexor Muscles in Very Young Children With Cerebral Palsy.

Authors:  Tiantian Wang; Lin Du; Ling Shan; Hanyu Dong; Junyan Feng; Maren C Kiessling; Nicholas B Angstman; Christoph Schmitz; Feiyong Jia
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

2.  The Effects of Extracorporeal Shock Wave Therapy on Spastic Muscle of the Wrist Joint in Stroke Survivors: Evidence From Neuromechanical Analysis.

Authors:  Yan Leng; Wai Leung Ambrose Lo; Chengpeng Hu; Ruihao Bian; Zhiqin Xu; Xiyao Shan; Dongfeng Huang; Le Li
Journal:  Front Neurosci       Date:  2021-01-21       Impact factor: 4.677

3.  Effect of extracorporeal shock wave therapy on spastic equinus foot in children with unilateral cerebral palsy.

Authors:  Hatem A Emara; Ahmed H Al-Johani; Osama A Khaled; Walaa M Ragab; Abdullah M Al-Shenqiti
Journal:  J Taibah Univ Med Sci       Date:  2022-02-26

4.  Effect of Early Radial Shock Wave Treatment on Spasticity in Subacute Stroke Patients: A Pilot Study.

Authors:  Stefano Brunelli; Noemi Gentileschi; Barbara Spanò; Luca Pratesi; Alessandra Calvani; Roberta Mucci; Calogero Foti
Journal:  Biomed Res Int       Date:  2022-07-20       Impact factor: 3.246

Review 5.  Shock waves in the treatment of muscle hypertonia and dystonia.

Authors:  Laura Mori; Lucio Marinelli; Elisa Pelosin; Antonio Currà; Luigi Molfetta; Giovanni Abbruzzese; Carlo Trompetto
Journal:  Biomed Res Int       Date:  2014-09-17       Impact factor: 3.411

6.  Effect of Radial Shock Wave Therapy on Spasticity of the Upper Limb in Patients With Chronic Stroke: A Prospective, Randomized, Single Blind, Controlled Trial.

Authors:  Tsung-Ying Li; Chih-Ya Chang; Yu-Ching Chou; Liang-Cheng Chen; Heng-Yi Chu; Shang-Lin Chiang; Shin-Tsu Chang; Yung-Tsan Wu
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

7.  Extracorporeal Shock Wave Stimulation as Alternative Treatment Modality for Wrist and Fingers Spasticity in Poststroke Patients: A Prospective, Open-Label, Preliminary Clinical Trial.

Authors:  Robert Dymarek; Jakub Taradaj; Joanna Rosińczuk
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-18       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.